Vasodilator pre-treatment of human radial arteries.

Ito M. Circadian variation of QT interval dispersion: correlation with heart rate variability. J Electrocardiol 1997; 30: 205–10. [9] Cinca J, Moya A, Figueras J, Roma F, Rius J. Circadian variations in the electrical properties of the human heart assessed by sequential bedside electrophysiologic testing. Am Heart J 1986; 112: 315–21. [10] Huikuri HV, Yli-Mayry S, Linnaluoto MK, Ikaheimo MJ. Diurnal fluctuations in human ventricular and atrial refractoriness. PACE 1995; 18: 1362–8. [11] Kong TQ, Goldberger JJ, Parker M, Wang T, Kadish AH. Circadian variation in human ventricular refractoriness. Circulation 1995; 92: 1507–16. [12] Willich SN, Goldberg RJ, Maclure M, Perriello L, Muller JE. Increased onset of sudden cardiac death in the first three hours after awakening. Am J Cardiol 1992; 70: 65–8. [13] Simantirakis EN, Chrysostomakis SI, Marketou ME et al. Atrial and ventricular refractoriness in paced patients. Circadian variation and its relation to autonomic nervous system activity. Eur Heart J 2001; 22: 2192–200, doi:10.1053/ euhj.2001.2677. [14] Franz MR, Swerdlow CD, Liem LB, Schaefer J. Cycle length dependence of human action potential duration in vivo. Effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different steady-state frequencies. J Clin Invest 1988; 82: 972–9. [15] Behrens S, Ehlers C, Brüggemann T et al. Modification of the circadian pattern of ventricular tachyarrhythmias by betablocker therapy. Clin Cardiol 1997; 20: 253–7. [16] Peters RW, Muller JE, Goldstein S, Byington R, Friedman LM. Propranolol and the morning increase in the frequency of sudden cardiac death (BHAT study). Am J Cardiol 1989; 63: 1518–20.